What PDS Life Sciences does

PDS Life Sciences, headquartered in Pratteln, Switzerland (founded 1980), is a software vendor serving the life sciences and preclinical research sectors. The company provides an integrated platform spanning preclinical study management, laboratory information management, in silico toxicology, quality management, and regulatory compliance, targeting pharmaceutical, biotechnology, contract research organization (CRO), contract development and manufacturing organization (CDMO), academic, and agrichemical customers. Core products include Provantis (preclinical software suite), Leadscope (in silico toxicology with Model Applier, KnowledgeScan, and Predict modules), Matrix Gemini LIMS, Centrus (data alignment and visualization), Pristima, and the newly launched Climb cloud platform with 21 CFR Part 11 compliance, eQCM (Quality System Management), and Compliance Builder. The platform supports regulatory standards including SEND (Standard for Exchange of Nonclinical Data) and serves more than 700 clients globally with multi-language support (English, Japanese, German, French).

The underlying technology combines validated enterprise software architectures with predictive toxicology knowledge bases and configurable workflow engines. Leadscope's Model Applier and Predict components use computational models for toxicity prediction, while KnowledgeScan supports target safety assessment from public and proprietary sources. The technology stack is being modernized through the Climb cloud-native platform while maintaining regulatory-grade data integrity requirements.

The business model is enterprise SaaS/software licensing with quote-based pricing, indicating high annual contract values typical of regulated life sciences deployments. The company pursues a multi-segment go-to-market spanning large pharma, biotech, CROs, CDMOs, academic institutions, and agrichemical companies, with global distribution evidenced by regional language support and user group meetings. The company's growth strategy combines organic product expansion (multiple newly launched products in the past year) with inorganic moves (Pristima acquisition) to build a comprehensive regulated workflow platform.

Name

PDS Life Sciences

Legal name

Instem

Website

https://pdslifesciences.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

PDS Life Sciences is a Swiss-headquartered software vendor providing validated preclinical, LIMS, in silico toxicology, and quality management platforms to 700+ life sciences clients across pharma, biotech, CRO, CDMO, academic, and agrichemical segments globally.

Ownership category

akta.pro rank

Product category

Life Sciences R&D Software

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Preclinical research software
• Life science R&D platforms
• Toxicology prediction software
• SEND submission solutions
• Laboratory information systems

Headquarters

HQ city

Pratteln

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. SaaS Platforms and Software Subscriptions: Instem generates revenue through SaaS platform subscriptions covering In Silico & Data Insights, Study Management, Regulatory Submission, and Clinical Trial Analytics. The subscription model provides recurring revenue from software-as-a-service delivery across their product portfolio.
2. Scientific and Regulatory Consulting Services: Instem Catalyst provides scientific and regulatory consulting services to strengthen R&D workflows, representing additional service revenue alongside software platforms.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

PDS Life Sciences develops and delivers integrated SaaS software platforms for life science and preclinical research, spanning in silico toxicology and data insights, preclinical and discovery study management, SEND-based regulatory submission, laboratory execution (LIMS), and clinical trial analytics. The portfolio addresses the full drug development lifecycle from target safety assessment through clinical trial transparency, and is complemented by scientific and regulatory consulting services. Customers include pharmaceutical, biotech, CRO, CDMO, academic, and agrichemical organizations worldwide.

Product overview

Instem is a SaaS platform provider offering an integrated portfolio of life science software solutions across five core areas: In Silico & Data Insights (Leadscope Model Applier, Predict, KnowledgeScan, Centrus, Advance), Study Management (Climb, Provantis, Morphit, Pristima, BioRails, Comet Assay IV, Logbook, NOTOCORD-hem, Cyto Study Manager), Regulatory Submission (SEND Advantage Services, eQCM, Submit, Compliance Builder), Lab Execution (Matrix Gemini LIMS), and Clinical Trial Analytics (Accel, Aspire, Blur, Custom SCE, CTT Services). The company also provides consulting services through Instem Catalyst. These products serve pharmaceutical, biotech, CRO, CDMO, academic research, and agrichemical organizations to enable data-driven decision making in drug research and development.

Differentiator

Problem solved

Functional benefit

Brands

• Leadscope: In silico toxicology and predictive analytics tools including Leadscope Model Applier for regulatory-driven toxicological endpoint predictions
• Provantis
• Climb
• Matrix Gemini LIMS
• Accel
• Aspire
• Blur
• Centrus
• BioRails
• Instem Catalyst

Products and services

• Leadscope Model Applier In silico software that delivers accurate predictions for wide-ranging toxicological endpoints in line with regulatory guidelines, used by R&D teams in pharmaceutical, biotech, CRO, CDMO, and agrichemical organizations.
• Predict Expert in silico toxicology reporting service producing reports with proven regulatory acceptance for life science R&D organizations.
• KnowledgeScan Target safety assessment service providing detailed insights into potential toxicological risks associated with drug targets for discovery and translational teams.
• Centrus Advanced translational safety software enabling data alignment, review, and visualizations across preclinical safety programs.
• Advance Expert-led S1B Weight of Evidence (WoE) assessment service that accelerates development timelines for regulatory submissions.
• Climb Cloud-based software for capturing pre-clinical in vivo data from any therapeutic area, accelerating non-GLP study execution.
• Provantis Market leading preclinical GLP study management software for regulated safety assessment studies.
• Morphit Discovery research software that simplifies capturing, analyzing, and reporting data to accelerate early-stage research.
• Pristima Legacy Xybion study management software supporting preclinical research operations.
• BioRails Discovery software optimizing bioanalysis workflows and accelerating in vitro ADME/DMPK and in vivo PK studies.
• Comet Assay IV Image analysis system that delivers consistent and reliable comet assay scoring for genetic toxicology studies.
• Logbook Digitalization software that replaces paper-based laboratory logbooks with electronic records.
• NOTOCORD-hem Software for advanced acquisition, analysis, and custom reporting of physiological signals in preclinical safety studies.
• Cyto Study Manager Comprehensive genetic toxicology assay management platform that consolidates workflows and reduces study costs.
• SEND Advantage Services Professional services providing accelerated submission-ready SEND conversions, consultation, and verification for regulatory submissions.
• Quality System Management (eQCM) Electronic quality management system supporting regulatory compliance processes for life sciences organizations.
• Submit Suite for quickly creating and managing high quality submission-ready SEND packages for regulatory filings.
• Compliance Builder

Quantifiable outcome

• Over 700 clients globally using Instem applications for regulatory data capture, analysis, and submission

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature10 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• LabWare: LabWare is a long-standing LIMS vendor widely used in regulated life science laboratories, including preclinical and pharma R&D environments, directly overlapping with PDS's study-execution/data-management niche.
• Instem: Instem provides SaaS platforms across preclinical study management, SEND regulatory submissions, LIMS, and in silico toxicology for pharma, CROs, and biotechs, making it the closest direct comparable to PDS Life Sciences' preclinical software focus.
• IDBS: IDBS (a Danaher company) provides scientific data management and informatics platforms for biopharma R&D, including preclinical research workflows that directly compete with PDS's domain.
• Dotmatics: Dotmatics (now part of Revvity) offers a scientific informatics platform spanning lab data, in vivo study management, and biological workflow capture, comparable to PDS's preclinical research focus.
• LabVantage: LabVantage provides an enterprise LIMS platform used across pharma, biotech, and CRO labs, overlapping with PDS's configurable, compliance-focused laboratory data management positioning.

Emerging players

• Certara: Certara focuses on model-informed drug development and regulatory science software, serving overlapping pharma R&D buyers with a more modeling/simulation-centric platform that competes for incremental informatics budget.

Broad incumbents

• Revvity (formerly PerkinElmer): Revvity operates life science informatics and lab software assets (including signals/biology platforms from the PerkinElmer and Dotmatics acquisitions) that overlap with PDS's preclinical and lab informatics specialty.
• Charles River Laboratories: Charles River is a major preclinical CRO whose internal study workflows drive demand for preclinical software like PDS's and whose broader Endosafe and informatics adjacencies make it a relevant incumbent customer/competitor.
• Thermo Fisher Scientific (SampleManager / Watson): Thermo Fisher's informatics brands (SampleManager LIMS, Watson) deliver regulated LIMS and lab data systems used by global pharma labs, competing with PDS in the same buyer environments as part of a much broader instrumentation and services portfolio.
• Dassault Systèmes BIOVIA: BIOVIA offers a broad scientific informatics and laboratory execution portfolio across life sciences R&D, including in vivo and in vitro workflows that overlap with PDS's preclinical use cases but as part of a much wider platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/instem
• Xx.com/pdslifesciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PDS Life Sciences